MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Impact of chronic LD treatment on metabolism, blood flow and blood-brain barrier permeability in the 6-OHDA rat model

    R.P. Lerner, Z. Bimpisidis, V. Jourdain, T. Chaly, M. Hellman, K. Graf, V. Dhawan, S. Dewey, A. Cenci, D. Eidelberg (Manhasset, NY, USA)

    Objective: To determine the effects of chronic LD treatment and induction of dyskinesias on cerebral metabolism, blood flow and blood-brain barrier permeability in 6-OHDA rat…
  • 2016 International Congress

    Correlation between neuro-behavioral symptoms, cognition and gait in patients with dementia with Lewy bodies (DLB)

    B. Tousi, L. Mourany (Cleveland, OH, USA)

    Objective: To determine the prevalence of neurobehavioral disturbances and their relationship to gait and cognitive impairment in DLB. Background: The recent literature has conceptualized that…
  • 2016 International Congress

    Study of striatal dopamine transporter function in Alzheimer’s disease with parkinsonism

    T. Yamamoto, A. Miyake, K. Ikeda, T. Furuya, T. Mitsufuji, Y. Ito, T. Sasaki, K. Takahashi, N. Tamura, I. Matsunari, A. Nobuo (Iruma-gun, Japan)

    Objective: To clarify the pathological basis for Alzheimer's disease (AD) with parkinsonism using striatal dopamine transporter (DAT) scan. Background: Pathological basis for parkinsonism in AD…
  • 2016 International Congress

    Synaptic biomarkers for cognitive decline in Lewy body dementias and Alzheimer’s disease. A mass spectrometry approach

    E. Bereczki, R.M.M. Branca, P.T. Francis, J.H. Baek, J. Lehtio, D. Aarsland (Huddinge, Sweden)

    Objective: The aim of our study is to understand the role of synaptic dysfunction in cognitive decline by comparing the whole proteome of Parkinson's disease…
  • 2016 International Congress

    Association between urine protein/creatinine ratio and cognitive dysfunction in Parkinson’s disease

    Y.S. Oh, J.S. Kim, K.S. Lee (Seoul, Korea)

    Objective: We investigated the relationship between proteinuria and cognitive dysfunction in patients with Parkinson's disease. Background: Impaired renal function and proteinuria have been associated with…
  • 2016 International Congress

    Performance in Montreal cognitive assessment and functional independence in Parkinsonian with normal mini-mental state examination

    R. Breder, M.A.A. Leite, B.L. Pessoa, C.O. Vilaça (Niterói, Brazil)

    Objective: 1. to describe the performance in Montreal Cognitive Assessment (MoCA) in a sample of Parkinson's disease patients with normal Mini-Mental State Examination (MMSE). 2.…
  • 2016 International Congress

    Predictors of dementia in Parkinson’s disease: A population-based cohort study

    A. Keener, K. Paul, A. Folle, J. Bronstein, B. Ritz (Los Angeles, CA, USA)

    Objective: To evaluate and describe characteristics of Parkinson's disease (PD) patients who develop dementia during follow-up in a longitudinal study. Background: Important non-motor features of…
  • 2016 International Congress

    Characteristics of drop outs in a longitudinal study on individuals at risk for a neurodegenerative disorder

    U. Suenkel, S. Heinzel, A.K. von Thaler, F. Metzger, G.W. Eschweiler, I. Liepelt-Scarfone, W. Maetzler, D. Berg (Tübingen, Germany)

    Objective: To evaluate potential differences in cognitive, motor and demographic factors between individuals who are lost to follow-up in the longitudinal Tuebinger evaluation of Risk…
  • 2016 International Congress

    Cognitive complaint in Parkinson’s disease patients with normal cognition

    R.F. Purri, L. Brennan, J. Rick, L. Chahine, N. Dahodwala, A. Chen-Plotkin, J.E. Duda, J.F. Morley, R.S. Akhtar, J.Q. Trojanowski, D. Weintraub (Philadelphia, PA, USA)

    Objective: To characterize cognitively normal PD patients who endorse cognitive complaint, and to assess their cognitive performance over time. Background: PD patients are at a…
  • 2016 International Congress

    Relation between personality trait and depression in Parkinson’s disease

    A. Kumon, Y. Kobayashi, M. Saruwatari, N. Kawashima, K. Hasegawa (Sagamihara, Japan)

    Objective: 1. To investigate personality trait of patients with Parkinson's disease (PD). 2. To clarify the relationship between personality trait and depression in patients with…
  • « Previous Page
  • 1
  • …
  • 189
  • 190
  • 191
  • 192
  • 193
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Life expectancy with and without Parkinson’s disease in the general population
    • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
    • An atypical and interesting feature of Parkinson´s disease
    • Nilotinib for treating MSA: A preclinical proof of concept study
    • Effect of marijuana on Essential Tremor: A case report
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley